研究業績

  1. ホーム
  2. 業績
  3. 研究業績
  4. 2020年
  1. 2022年
  2. 2021年
  3. 2020年
  4. 2019年
  5. 2018年
  6. 2017年
  7. 2016年
  8. 2015年
  9. 2014年
  10. 2013年
  11. 2012年
  12. 2011年
  13. 2010年
  14. 2009年
  15. 2008年
  16. 2007年
  17. 2006年
  18. 2005年
  19. 2004年

2020年研究業績

英文総説

  1. Teshima T. Create a healthy diet after transplant!
    Blood. 2020 Jul 2;136(1):8-9. PMID: 32614959
  2. ImmGen at 15.
    Immunological Genome Project. (Daigo Hashimoto)
    Nat Immunol. 2020 Jul;21(7):700-703. PMID: 32577013

英文原著

  1. Matsuoka S, Hashimoto D, Kadowaki M, Ohigashi H, Hayase E, Yokoyama E, Hasegawa Y, Tateno T, Chen X, Aoyama K, Oka H, Onozawa M, Takeda K, Akashi K, Teshima T. Myeloid differentiation factor 88 signaling in donor T cells accelerates graft-versus-host disease. Haematologica. 2020 Jan;105(1):226-234. doi: 10.3324/haematol.2018.203380. Epub 2019 May 2. PMID: 31048358
  2. Peled JU, Gomes ALC, Devlin SM, Littmann ER, Taur Y, Sung AD, Weber D, Hashimoto D, Slingerland AE, Slingerland JB, Maloy M, Clurman AG, Stein-Thoeringer CK, Markey KA, Docampo MD, Burgos da Silva M, Khan N, Gessner A, Messina JA, Romero K, Lew MV, Bush A, Bohannon L, Brereton DG, Fontana E, Amoretti LA, Wright RJ, Armijo GK, Shono Y, Sanchez-Escamilla M, Castillo Flores N, Alarcon Tomas A, Lin RJ, Yáñez San Segundo L, Shah GL, Cho C, Scordo M, Politikos I, Hayasaka K, Hasegawa Y, Gyurkocza B, Ponce DM, Barker JN, Perales MA, Giralt SA, Jenq RR, Teshima T, Chao NJ, Holler E, Xavier JB, Pamer EG, van den Brink MRM. Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation. N Engl J Med. 2020 Feb 27;382(9):822-834. doi: 10.1056/NEJMoa1900623. PMID: 32101664
  3. Maziarz RT, Waller EK, Jaeger U, Fleury I, McGuirk J, Holte H, Jaglowski S, Schuster SJ, Bishop MR, Westin JR, Mielke S, Teshima T, Bachanova V, Foley SR, Borchmann P, Salles GA, Zhang J, Tiwari R, Pacaud LB, Ma Q, Tam CS. Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma. Blood Adv. 2020 Feb 25;4(4):629-637. doi: 10.1182/bloodadvances.2019001026. PMID: 32074277
  4. Nishiwaki S, Miyamura K, Kanda Y, Takanashi M, Uchida N, Fukuda T, Ikegame K, Ohashi K, Eto T, Ozawa Y, Shiratori S, Iwato K, Matsuoka KI, Hidaka M, Ichinohe T, Atsuta Y, Kodera Y, Okamoto S. A consideration for efficient unrelated hematopoietic stem cell source acquisition-from an experience of Japan. Bone Marrow Transplant. 2020 Mar;55(3):657-660. doi: 10.1038/s41409-019-0542-0. Epub 2019 May 14. PMID: 31089273
  5. Kanda Y, Kimura SI, Iino M, Fukuda T, Sakaida E, Oyake T, Yamaguchi H, Fujiwara SI, Jo Y, Okamoto A, Fujita H, Takamatsu Y, Saburi Y, Matsumura I, Yamanouchi J, Shiratori S, Gotoh M, Nakamura S, Tamura K; Japan Febrile Neutropenia Study Group. D-Index-Guided Early Antifungal Therapy Versus Empiric Antifungal Therapy for Persistent Febrile Neutropenia: A Randomized Controlled Noninferiority Trial. J Clin Oncol. 2020 Mar 10;38(8):815-822. doi: 10.1200/JCO.19.01916. Epub 2020 Jan 24. PMID: 31977270
  6. Shiratori S, Ohigashi H, Takahashi S, Ara T, Goto H, Nakagawa M, Sugita J, Onozawa M, Kahata K, Endo T, Hashimoto D, Teshima T; North Japan Hematology Study Group (NJHSG). Reduced dose of MTX for GVHD prophylaxis promotes engraftment and decreases non-relapse mortality in umbilical cord blood transplantation. Ann Hematol. 2020 Mar;99(3):591-598. doi: 10.1007/s00277-020-03937-3. Epub 2020 Feb 1. PMID: 32006152
  7. Fukutsu K, Namba K, Iwata D, Mizuuchi K, Kase S, Suzuki K, Shimizu H, Shibata Y, Yamawaki F, Onozawa M, Ishida S. Pseudo-inflammatory manifestations of choroidal lymphoma resembling Vogt-Koyanagi-Harada disease: case report based on multimodal imaging. BMC Ophthalmol. 2020 Mar 10;20(1):94. doi: 10.1186/s12886-020-01353-9. PMID: 32156266
  8. Fuji S, Oshima K, Ohashi K, Sawa M, Saito T, Eto T, Tanaka M, Onizuka M, Nakamae H, Shiratori S, Ozawa Y, Hidaka M, Nagamura-Inoue T, Tanaka H, Fukuda T, Ichinohe T, Atsuta Y, Ogata M. Impact of pretransplant donor-specific anti-HLA antibodies on cord blood transplantation on behalf of the Transplant Complications Working Group of Japan Society for Hematopoietic Cell Transplantation. Bone Marrow Transplant. 2020 Apr;55(4):722-728. doi: 10.1038/s41409-019-0712-0. Epub 2019 Oct 7. PMID: 31591450
  9. Fujimoto A, Hiramoto N, Yamasaki S, Inamoto Y, Ogata M, Sugio Y, Fukuda T, Uchida N, Ikegame K, Matsuoka KI, Shiratori S, Kondo T, Miyamoto T, Eto T, Ichinohe T, Kanda Y, Atsuta Y, Suzuki R; Complication Working Group of the Japan Society for Hematopoietic Cell Transplantation. Low incidence of posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximab. Hematol Oncol. 2020 Apr;38(2):146-152. doi: 10.1002/hon.2714. Epub 2020 Feb 3. PMID: 31953867
  10. Shimada K, Yamaguchi M, Atsuta Y, Matsue K, Sato K, Kusumoto S, Nagai H, Takizawa J, Fukuhara N, Nagafuji K, Miyazaki K, Ohtsuka E, Okamoto M, Sugita Y, Uchida T, Kayukawa S, Wake A, Ennishi D, Kondo Y, Izumi T, Kin Y, Tsukasaki K, Hashimoto D, Yuge M, Yanagisawa A, Kuwatsuka Y, Shimada S, Masaki Y, Niitsu N, Kiyoi H, Suzuki R, Tokunaga T, Nakamura S, Kinoshita T. Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial. Lancet Oncol. 2020 Apr;21(4):593-602. doi: 10.1016/S1470-2045(20)30059-0. Epub 2020 Mar 11. PMID: 32171071
  11. Yokoyama E, Hashimoto D, Hayase E, Ara T, Ogasawara R, Takahashi S, Ohigashi H, Tateno T, Hasegawa Y, Chen X, Teshima T. Short-term KRP203 and posttransplant cyclophosphamide for graft-versus-host disease prophylaxis. Bone Marrow Transplant. 2020 Apr;55(4):787-795. doi: 10.1038/s41409-019-0733-8. Epub 2019 Nov 4. PMID: 31685933
  12. Sato K, Ujiie H, Nakazato S, Watanabe M, Watanabe E, Yanagi T, Nakamaru Y, Takagi D, Arai R, Onodera T, Kondo T, Teshima T, Shimizu H. Rosai-Dorfman disease: earlier spontaneous regression of skin lesions relative to nasal, pharyngeal, and bone lesions. Eur J Dermatol. 2020 Apr 1;30(2):182-183. doi: 10.1684/ejd.2020.3718. PMID: 32538360
  13. Senjo H, Hirata K, Izumiyama K, Minauchi K, Tsukamoto E, Itoh K, Kanaya M, Mori A, Ota S, Hashimoto D, Teshima T; North Japan Hematology Study Group. High metabolic heterogeneity on baseline 18FDG-PET/CT scan as a poor prognostic factor for newly diagnosed diffuse large B-cell lymphoma. Blood Adv. 2020 May 26;4(10):2286-2296. doi: 10.1182/bloodadvances.2020001816. PMID: 32453838
  14. Matsuda K, Ono S, Tanaka I, Inoue M, Kinowaki S, Ishikawa M, Tsuda M, Yamamoto K, Shimizu Y, Takahashi S, Hayase E, Hashimoto D, Teshima T, Sakamoto N. Histological and magnified endoscopic evaluation of villous atrophy in gastrointestinal graft-versus-host disease. Ann Hematol. 2020 May;99(5):1121-1128. doi: 10.1007/s00277-020-03966-y. Epub 2020 Mar 4. PMID: 32130472
  15. Zeiser R, von Bubnoff N, Butler J, Mohty M, Niederwieser D, Or R, Szer J, Wagner EM, Zuckerman T, Mahuzier B, Xu J, Wilke C, Gandhi KK, Socié G; REACH2 Trial Group. Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease. N Engl J Med. 2020 May 7;382(19):1800-1810. doi: 10.1056/NEJMoa1917635. Epub 2020 Apr 22. PMID: 32320566
  16. Kurosawa S, Mori A, Tsukagoshi M, Onishi Y, Ohwada C, Mori T, Goto H, Asano-Mori Y, Nawa Y, Hino M, Fukuchi T, Mori Y, Yamahana R, Inamoto Y, Fukuda T. Current status and needs of long-term follow-up clinics for hematopoietic cell transplantation survivors: Results of a nationwide survey in Japan. Biol Blood Marrow Transplant. 2020 May;26(5):949-955. PMID: 31962164
  17. Hidaka D, Onozawa M, Miyashita N, Yokoyama S, Nakagawa M, Hashimoto D, Teshima T. Short-term treatment with imetelstat sensitizes hematopoietic malignant cells to a genotoxic agent via suppression of the telomerase-mediated DNA repair process. Leuk Lymphoma. 2020 Jun 22:1-11. doi: 10.1080/10428194.2020.1779256. Online ahead of print. PMID: 32571117
  18. Mehta RS, Holtan SG, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel DR, Alousi AM, Pidala J, Abdel-Azim H, Agrawal V, Ahmed I, Al-Homsi AS, Aljurf M, Antin JH, Askar M, Auletta JJ, Bhatt VR, Chee L, Chhabra S, Daly A, DeFilipp Z, Gajewski J, Gale RP, Gergis U, Hematti P, Hildebrandt GC, Hogan WJ, Inamoto Y, Martino R, Majhail NS, Marks DI, Nishihori T, Olsson RF, Pawarode A, Diaz MA, Prestidge T, Rangarajan HG, Ringden O, Saad A, Savani BN, Schoemans H, Seo S, Schultz KR, Solh M, Spitzer T, Storek J, Teshima T, Verdonck LF, Wirk B, Yared JA, Cahn JY, Weisdorf DJ. Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT. J Clin Oncol. 2020 Jun 20;38(18):2062-2076. doi: 10.1200/JCO.19.00396. Epub 2020 May 4. PMID: 32364845
  19. Hattori T, Amishima M, Morinaga D, Kamada K, Nakakubo S, Yamashita Y, Shichinohe Y, Fujisawa S, Nishida M, Nasuhara Y, Teshima T, Konno S. Older age is associated with sustained detection of SARS-CoV-2 in nasopharyngeal swab samples. J Infect. 2020 Jun 21;82(1):159-98. doi: 10.1016/j.jinf.2020.06.046. Online ahead of print. PMID: 32579989
  20. Ara T, Hashimoto D, Hayase E, Noizat C, Kikuchi R, Hasegawa Y, Matsuda K, Ono S, Matsuno Y, Ebata K, Ogasawara R, Takahashi S, Ohigashi H, Yokoyama E, Matsuo K, Sugita J, Onozawa M, Okumura R, Takeda K, Teshima T. Intestinal goblet cells protect against GVHD after allogeneic stem cell transplantation via Lypd8. Sci Transl Med. 2020 Jul 1;12(550):eaaw0720. doi: 10.1126/scitranslmed.aaw0720. PMID: 32611682
  21. Terakura S, Nishida T, Sawa M, Kato T, Miyao K, Ozawa Y, Goto T, Kohno A, Ozeki K, Onishi Y, Fukuhara N, Fujii N, Yokoyama H, Kasai M, Iida H, Kanemura N, Endo T, Ago H, Onizuka M, Iyama S, Nawa Y, Nakamae M, Nagata Y, Kurahashi S, Tomiya Y, Yanagisawa A, Suzuki R, Kuwatsuka Y, Atsuta Y, Miyamura K, Murata M; Nagoya Blood and Marrow Transplantation Group. Prospective evaluation of alternative donor from unrelated donor and cord blood in adult acute leukemia and myelodysplastic syndrome. Bone Marrow Transplant. 2020 Jul;55(7):1399-1409. doi: 10.1038/s41409-020-0859-8. Epub 2020 Mar 16.PMID: 32203259
  22. Yonese I, Sakashita C, Imadome KI, Kobayashi T, Yamamoto M, Sawada A, Ito Y, Fukuhara N, Hirose A, Takeda Y, Makita M, Endo T, Kimura SI, Ishimura M, Miura O, Ohga S, Kimura H, Fujiwara S, Arai A. Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification. Blood Adv. 2020 Jul 14;4(13):2918-2926. doi: 10.1182/bloodadvances.2020001451. PMID: 32598475
  23. Akahoshi Y, Nishiwaki S, Arai Y, Harada K, Najima Y, Kanda Y, Shono K, Ota S, Fukuda T, Uchida N, Shiratori S, Tanaka M, Tanaka J, Atsuta Y, Kako S. Reduced-intensity conditioning is a reasonable alternative for Philadelphia chromosome-positive acute lymphoblastic leukemia among elderly patients who have achieved negative minimal residual disease: a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSHCT. Bone Marrow Transplant. 2020 Jul;55(7):1317-1325. doi: 10.1038/s41409-020-0951-0. Epub 2020 May 23. PMID: 32447350
  24. Shiratori S, Sugita J, Ota S, Kasahara S, Ishikawa J, Tachibana T, Hayashi Y, Yoshimoto G, Eto T, Iwasaki H, Harada M, Matsuo K, Teshima T; Japan Study Group for Cell Therapy and Transplantation (JSCT). Low-dose anti-thymocyte globulin for GVHD prophylaxis in HLA-matched allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant. 2020 Jul 5. doi: 10.1038/s41409-020-0985-3. Online ahead of print. PMID: 32624582
  25. Nishikawa K, Kimura K, Kanda Y, Sugiyama M, Kakihana K, Doki N, Ohashi K, Bae SK, Takahashi K, Ishihara Y, Mizuno I, Onishi Y, Onozawa M, Onizuka M, Yamamoto M, Ishikawa T, Inoue K, Kusumoto S, Hashino S, Saito H, Kanto T, Sakamaki H, Mizokami M. A prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2020 Jul;55(7):1388-1398. doi: 10.1038/s41409-020-0833-5. Epub 2020 Feb 18. PMID: 32071416
  26. Sakakibara-Konishi J, Sato M, Sato MT, Kasahara K, Onozawa M, Mizugaki H, Kikuchi E, Asahina H, Shinagawa N, Konno S. Nivolumab-induced immune thrombocytopenia in a patient with malignant pleural mesothelioma. Respir Med Case Rep. 2020 Jul 17;31:101170. doi: 10.1016/j.rmcr.2020.101170. eCollection 2020. PMID: 32714828
  27. Kanda J, Umeda K, Kato K, Murata M, Sugita J, Adachi S, Koh K, Noguchi M, Goto H, Yoshida N, Sato M, Koga Y, Hori T, Cho Y, Ogawa A, Inoue M, Hashii Y, Atsuta Y, Teshima T; JSHCT GVHD Working Group. Effect of graft-versus-host disease on outcomes after pediatric single cord blood transplantation. Bone Marrow Transplant. 2020 Jul;55(7):1430-1437. doi: 10.1038/s41409-020-0853-1. Epub 2020 Mar 11. PMID: 32161321
  28. Mori T, Shiratori S, Suzumiya J, Kurokawa M, Shindo M, Naoyuki U, Katsuto T, Miyamoto T, Morishige S, Hirokawa M, Fukuda T, Atsuta Y, Suzuki R. Outcome of allogeneic hematopoietic stem cell transplantation for mycosis fungoides and Sézary syndrome. Hematol Oncol. 2020 Aug;38(3):266-271. doi: 10.1002/hon.2719. Epub 2020 Mar 3. PMID: 32011008
  29. Iwasaki S, Fujisawa S, Nakakubo S, Kamada K, Yamashita Y, Fukumoto T, Sato K, Oguri S, Taki K, Senjo H, Sugita J, Hayasaka K, Konno S, Nishida M, Teshima T. Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva. J Infect. 2020 Aug;81(2):e145-e147. doi: 10.1016/j.jinf.2020.05.071. Epub 2020 Jun 4. PMID: 32504740
  30. Shimono J, Izumiyama K, Ito S, Tsutsmi Y, Kondo T, Kakinoki Y, Teshima T. Lymphocyte-monocyte ratio (LMR) can predict bendamustine therapeutic efficacy in low-grade B-cell lymphoma. Int J Lab Hematol. 2020 Aug;42(4):431-438. doi: 10.1111/ijlh.13216. Epub 2020 Apr 28. PMID: 32343486
  31. Im A, Rashidi A, Wang T, Hemmer M, MacMillan ML, Pidala J, Jagasia M, Pavletic S, Majhail NS, Weisdorf D, Abdel-Azim H, Agrawal V, Al-Homsi AS, Aljurf M, Askar M, Auletta JJ, Bashey A, Beitinjaneh A, Bhatt VR, Byrne M, Cahn JY, Cairo M, Castillo P, Cerny J, Chhabra S, Choe H, Ciurea S, Daly A, Perez MAD, Farhadfar N, Gadalla SM, Gale R, Ganguly S, Gergis U, Hanna R, Hematti P, Herzig R, Hildebrandt GC, Lad DP, Lee C, Lehmann L, Lekakis L, Kamble RT, Kharfan-Dabaja MA, Khandelwal P, Martino R, Murthy HS, Nishihori T, O'Brien TA, Olsson RF, Patel SS, Perales MA, Prestidge T, Qayed M, Romee R, Schoemans H, Seo S, Sharma A, Solh M, Strair R, Teshima T, Urbano-Ispizua A, Van der Poel M, Vij R, Wagner JL, William B, Wirk B, Yared JA, Spellman SR, Arora M, Hamilton BK. Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide. Biol Blood Marrow Transplant. 2020 Aug;26(8):1459-1468. doi: 10.1016/j.bbmt.2020.05.001. Epub 2020 May 17. PMID: 32434056
  32. Sekiguchi N, Rai S, Munakata W, Suzuki K, Handa H, Shibayama H, Endo T, Terui Y, Iwaki N, Fukuhara N, Tatetsu H, Iida S, Ishikawa T, Shiibashi R, Izutsu K. A multicenter, open-label, phase II study of tirabrutinib (ONO/GS-4059) in patients with Waldenström's macroglobulinemia. Cancer Sci. 2020 Sep;111(9):3327-3337. doi: 10.1111/cas.14561. Epub 2020 Jul 20.PMID: 32639651
  33. Kimura SI, Kanda Y, Iino M, Fukuda T, Sakaida E, Oyake T, Yamaguchi H, Fujiwara SI, Jo Y, Okamoto A, Fujita H, Takamatsu Y, Saburi Y, Matsumura I, Yamanouchi J, Shiratori S, Gotoh M, Nakamura S, Tamura K; Japan Febrile Neutropenia Study Group. Efficacy and safety of micafungin in empiric and D-index-guided early antifungal therapy for febrile neutropenia; A subgroup analysis of the CEDMIC trial. Int J Infect Dis. 2020 Sep 3;100:292-297. doi: 10.1016/j.ijid.2020.08.081. Online ahead of print. PMID: 32891738
  34. Goto H, Hidaka D, Yamamoto S, Hayasaka K, Michimata R, Kagawa I, Sunagoya K, Iijima H, Hayase E, Shiratori S, Okada K, Sugita J, Onozawa M, Hashimoto D, Kahata K, Fujimoto K, Endo T, Shimizu C, Teshima T; North Japan Hematology Study Group (NJHSG). Feasibility and efficacy of low-dose pegfilgrastim for CD34+ cell mobilization in lymphoma. J Clin Apher. 2020 Sep;35(5):413-419. doi: 10.1002/jca.21816. Epub 2020 Jul 29. PMID: 33043486
  35. Matsukawa T, Suto K, Kanaya M, Izumiyama K, Minauchi K, Yoshida S, Oda H, Miyagishima T, Mori A, Ota S, Hashimoto D, Teshima T; North Japan Hematology Study Group (NJHSG). Validation and comparison of prognostic values of GNRI, PNI, and CONUT in newly diagnosed diffuse large B cell lymphoma. Ann Hematol. 2020 Sep 24. doi: 10.1007/s00277-020-04262-5. Online ahead of print. PMID: 32970194
  36. Sugita J, Kamimura T, Ishikawa T, Ota S, Eto T, Kuroha T, Miyazaki Y, Kumagai H, Matsuo K, Akashi K, Taniguchi S, Harada M, Teshima T. Reduced dose of posttransplant cyclophosphamide in HLA-haploidentical peripheral blood stem cell transplantation. Bone Marrow Transplant. 2020 Sep 24. doi: 10.1038/s41409-020-01065-0. Online ahead of print. PMID: 32973350
  37. Yokota I, Shane PY, Okada K, Unoki Y, Yang Y, Inao T, Sakamaki K, Iwasaki S, Hayasaka K, Sugita J, Nishida M, Fujisawa S, Teshima T. Mass screening of asymptomatic persons for SARS-CoV-2 using saliva. Clin Infect Dis. 2020 Sep 25:ciaa1388. doi: 10.1093/cid/ciaa1388. Online ahead of print. PMID: 32976596
  38. Fukumoto T, Iwasaki S, Fujisawa S, Hayasaka K, Sato K, Oguri S, Taki K, Nakakubo S, Kamada K, Yamashita Y, Konno S, Nishida M, Sugita J, Teshima T. Efficacy of a novel SARS-CoV-2 detection kit without RNA extraction and purification. Int J Infect Dis. 2020 Sep;98:16-17. doi: 10.1016/j.ijid.2020.06.074. Epub 2020 Jun 26. PMID: 32599282
  39. Goto H, Makita S, Kato K, Tokushige K, Fujita T, Akashi K, Izutsu K, Teshima T. Efficacy and safety of tisagenlecleucel in Japanese adult patients with relapsed/refractory diffuse large B-cell lymphoma. Int J Clin Oncol. 2020 Sep;25(9):1736-1743. doi: 10.1007/s10147-020-01699-6. Epub 2020 May 24. PMID: 32448949
  40. Goto H, Hidaka D, Yamamoto S, Hayasaka K, Michimata R, Kagawa I, Sunagoya K, Iijima H, Hayase E, Shiratori S, Okada K, Sugita J, Onozawa M, Hashimoto D, Kahata K, Fujimoto K, Endo T, Shimizu C, Teshima T; North Japan Hematology Study Group (NJHSG). Feasibility and efficacy of low-dose pegfilgrastim for CD34+ cell mobilization in lymphoma. J Clin Apher. 2020 Sep;35(5):413-419. PMID: 33043486
  41. Onishi Y, Yokoyama H, Katsuoka Y, Ito T, Kimura T, Yamamoto J, Nakajima S, Sasaki O, Ara T, Minauchi K, Fukuhara O, Kobayashi N, Noji H, Ota S, Harigae H. Low-dose lenalidomide and dexamethasone therapy after melphalan-prednisolone induction in elderly patients with newly diagnosed multiple myeloma. Ann Hematol. 2020 Oct;99(10):2351-2356. doi: 10.1007/s00277-020-04240-x. Epub 2020 Aug 31. PMID: 32865607
  42. Yamashita T, Takami A, Uchida N, Fukuda T, Eto T, Shiratori S, Ota S, Akasaka T, Miyakoshi S, Kondo T, Hidaka M, Kanda J, Atsuta Y, Yano S. Reduced-intensity stem cell transplantation for acute myeloid leukemia with fludarabine-based conditioning with intravenous busulfan versus melphalan. Bone Marrow Transplant. 2020 Oct;55(10):1955-1965. doi: 10.1038/s41409-020-0856-y. Epub 2020 Mar 12. PMID: 32203256
  43. Kagami K, Ishiguro N, Yamada T, Niinuma Y, Iwasaki S, Taki K, Fukumoto T, Hayasaka K, Oyamada R, Watanabe T, Nishida M, Sugita J, Teshima T, Sugawara M, Takekuma Y. Efficacy and safety of colistin for the treatment of infections caused by multidrug-resistant gram-negative bacilli. J Infect Chemother. 2020 Oct 31:S1341-321X(20)30383-4. doi: 10.1016/j.jiac.2020.10.024. Online ahead of print. PMID: 33144146
  44. Kitagataya T, Suda G, Nagashima K, Katsurada T, Yamamoto K, Kimura M, Maehara O, Yamada R, Shigesawa T, Suzuki K, Nakamura A, Ohara M, Umemura M, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Ohnishi S, Komatsu Y, Hata H, Takeuchi S, Abe T, Sakakibara-Konishi J, Teshima T, Homma A, Sakamoto N. Prevalence, clinical course, and predictive factors of immune checkpoint inhibitor monotherapy-associated hepatitis in Japan. J Gastroenterol Hepatol. 2020 Oct;35(10):1782-1788. doi: 10.1111/jgh.15041. Epub 2020 Mar 31. PMID: 32187734
  45. Uchida N, Matsumoto K, Sakura T, Hidaka M, Miyamoto T, Eto T, Maeda Y, Murayama T, Fujishima N, Yoshimoto G, Morita K, Kishimoto J, Teshima T, Taniguchi S, Yamashita T, Mori SI, Akashi K, Harada M; Japan Study Group for Cell Therapy, Transplantation (JSCT). Myeloablative intravenous busulfan-containing regimens for allo-HSCT in AML or MDS patients over 54 years old: combined results of three phase II studies. Int J Hematol. 2020 Oct;112(4):510-523. doi: 10.1007/s12185-020-02941-7. Epub 2020 Jul 12. PMID: 32656637
  46. Iida S, Ishida T, Horimoto K, Kazama H, Kim H, Crawford B, Teshima T. Medical database analysis of japanese multiple myeloma patients with planned stem cell transplantation (MEDALIST) - a focus on healthcare resource utilization and cost. Int J Hematol. 2020 Oct 15. doi: 10.1007/s12185-020-03022-5. Online ahead of print. PMID: 33063174
  47. Taki K, Yokota I, Fukumoto T, Iwasaki S, Fujisawa S, Takahashi M, Negishi S, Hayasaka K, Sato K, Oguri S, Nishida M, Sugita J, Konno S, Saito T, Teshima T. SARS-CoV-2 detection by fluorescence loop-mediated isothermal amplification with and without RNA extraction. J Infect Chemother. 2020 Oct 31:S1341-321X(20)30399-8. doi: 10.1016/j.jiac.2020.10.029. Online ahead of print. PMID: 33214073
  48. Yokota I, Shane PY, Okada K, Unoki Y, Yang Y, Iwasaki S, Fujisawa S, Nishida M, Teshima T. A Novel Strategy for SARS-CoV-2 Mass-Screening Using Quantitative Antigen Testing of Saliva. SSRN Electronic Journal. 2020 Oct. doi: 10.2139/ssrn.3719066.
  49. Shiratori S, Ohigashi H, Ara T, Yasumoto A, Goto H, Nakagawa M, Sugita J, Onozawa M, Kahata K, Endo T, Hashimoto D, Teshima T. High lymphocyte counts before antithymocyte globulin administration predict acute graft-versus-host disease. Ann Hematol. 2020 Nov 19. doi: 10.1007/s00277-020-04347-1. Online ahead of print. PMID: 33215225
  50. Senjo H, Onozawa M, Hidaka D, Yokoyama S, Yamamoto S, Tsutsumi Y, Haseyama Y, Nagashima T, Mori A, Ota S, Sakai H, Ishihara T, Miyagishima T, Kakinoki Y, Kurosawa M, Kobayashi H, Iwasaki H, Hashimoto D, Kondo T, Teshima T. A novel nutritional index "simplified CONUT" and the disease risk index independently stratify prognosis of elderly patients with acute myeloid leukemia. Sci Rep. 2020 Nov 10;10(1):19400. doi: 10.1038/s41598-020-76250-8. PMID: 33173122
  51. Ito A, Kim SW, Matsuoka KI, Kawakita T, Tanaka T, Inamoto Y, Toubai T, Fujiwara SI, Fukaya M, Kondo T, Sugita J, Nara M, Katsuoka Y, Imai Y, Nakazawa H, Kawashima I, Sakai R, Ishii A, Onizuka M, Takemura T, Terakura S, Iida H, Nakamae M, Higuchi K, Tamura S, Yoshioka S, Togitani K, Kawano N, Suzuki R, Suzumiya J, Izutsu K, Teshima T, Fukuda T. Safety and efficacy of anti-programmed cell death-1 monoclonal antibodies before and after allogeneic hematopoietic cell transplantation for relapsed or refractory Hodgkin lymphoma: a multicenter retrospective study. Int J Hematol. 2020 Nov;112(5):674-689. doi: 10.1007/s12185-020-02960-4. Epub 2020 Aug 3. PMID: 32748216
  52. Takezako N, Kosugi H, Matsumoto M, Iida S, Ishikawa T, Kondo Y, Ando K, Miki H, Matsumura I, Sunami K, Teshima T, Iwasaki H, Onishi Y, Kizaki M, Izutsu K, Maruyama D, Tobinai K, Ghori R, Farooqui M, Liao J, Marinello P, Matsuda K, Koh Y, Shimamoto T, Suzuki K. Pembrolizumab plus lenalidomide and dexamethasone in treatment-naive multiple myeloma (KEYNOTE-185): subgroup analysis in Japanese patients. Int J Hematol. 2020 Nov;112(5):640-649. doi: 10.1007/s12185-020-02953-3. Epub 2020 Sep 19. PMID: 32949374
  53. Wang, H., Wei, W., Zhang, JP., Song, Z., Li, Y., Xiao, W., Liu, Y., Zeng, MS., Petrus, MN., Thomas, CJ., Kadin, ME., Nakagawa, M., Waldmann, TA., Yang, Y. A novel model of alternative NF-kappaB pathway activation in anaplastic large cell lymphoma. Leukemia 2020 in press. PMID: 33184494
  54. Kazuki Uchiyama, Yoshitaka Saito, Yoh Takekuma, Junichi Sugita, Takanori Teshima, Mitsuru Sugawara. Pharmacokinetics of mycophenolic acid after haplo-hematopoietic stem cell transplantation in Japanese recipients. J Oncol Pharm Pract. 2020 Dec 22;1078155220980815. doi: 10.1177/1078155220980815. Online ahead of print. PMID: 33349149.
  55. Fujimoto K, Hatanaka KC, Hatanaka Y, Kasahara I, Yamamoto S, Tsuji T, Nakata M, Takakuwa Y, Haseyama Y, Oyamada Y, Yonezumi M, Suzuki H, Sakai H, Noguchi H, Mori A, Nishihara H, Teshima T, Matsuno Y. Association of Epstein-Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with autoimmune diseases. Hematol Oncol. 2020 Dec;38(5):799-807. doi: 10.1002/hon.2790. Epub 2020 Aug 21. PMID: 32798315

英文症例報告

  1. Goto R, Kawamura N, Watanabe M, Koshizuka Y, Shiratori S, Ara M, Honda S, Mitsuhashi T, Matsuno Y, Shimamura T, Taketomi A. Post-transplant indolent T cell lymphoproliferative disorder in living donor liver transplantation: a case report. Surg Case Rep. 2020 Jun 26;6(1):147. doi: 10.1186/s40792-020-00904-y. PMID: 32588353
  2. Kawamura N, Goto R, Koshizuka Y, Watanabe M, Suzuki T, Endo T, Kondo T, Taketomi A, Shimamura T. Second Case of Deceased Donor Liver Transplantation in a Patient Co-infected with HIV and HCV in Japan: Special Reference to the Management of Complicated Coagulopathy Due to a Diverse Spectrum of Preformed Anti-HLA Antibodies. Jpn J Infect Dis. 2020 Sep 24;73(5):369-372. doi: 10.7883/yoken.JJID.2019.487. Epub 2020 Apr 30.PMID: 32350218
  3. Otagiri S, Nakajima S, Katsurada T, Sakurai K, Yamanashi K, Ara T, Takakuwa E, Mitsuhashi T, Sakamoto N. Chronic Diarrhea as the Presenting Feature of Amyloidosis with Multiple Myeloma: A Case Report Diagnosed by a Myocardial Biopsy. Intern Med. 2020 Nov 16. doi: 10.2169/internalmedicine.6038-20. Online ahead of print. PMID: 33191327
  4. Yuki Fujiwara, Ken-Ichi Matsuoka, Miki Iwamoto, Yuichi Sumii, Masaya Abe, Kentaro Mizuhara, Tomohiro Urata, Kyosuke Saeki, Yusuke Meguri, Noboru Asada, Daisuke Ennishi, Hisakazu Nishimori, Keiko Fujii, Nobuharu Fujii, Junichi Sugita, Hajime Kobayashi, Takahiro Oto, Yoshinobu Maeda. Allogeneic hematopoietic stem cell transplantation in a prior lung transplant recipient. Int J Hematol. 2020 Dec;112(6):871-877. doi: 10.1007/s12185-020-02967-x. Epub 2020 Aug 17. PMID: 32803699

和文総説

  1. 同種造血幹細胞移植における免疫チェックポイント阻害薬
    Author：橋本 大吾
    Source： 日本造血細胞移植学会雑誌 (2186-5612)9巻1号 Page13-22(2020.01)
  2. 話題のくすり　チサゲンレクルユーセル
    Author：豊嶋 崇徳
    Source： 日本病院薬剤師会雑誌 (1341-8815)56巻1号 Page101-104(2020.01)
  3. 造血幹細胞移植療法の進歩
    Author：豊嶋 崇徳
    Source： 日本輸血細胞治療学会誌 (1881-3011)66巻1号 Page3-6(2020.02)
  4. 免疫・炎症・アレルギーおよび骨・関節の病気とくすり　免疫・炎症・アレルギー疾患　移植片対宿主病(解説/特集)
    Author：豊嶋 崇徳, 久保田 康生
    Source： 薬局 (0044-0035)71巻4号 Page830-845(2020.03)
  5. 同種造血幹細胞移植の動物モデル
    Author：橋本 大吾
    Source： 臨床血液 (0485-1439)61巻4号 Page369-378(2020.04)
  6. 大腸杯細胞は抗菌分子Lypd8依存性に同種造血幹細胞移植後の移植片対宿主病を抑制する
    Author：荒 隆英, 橋本 大吾, 早瀬 英子, Noizat Clara, 菊池 遼, 長谷川 祐太, 奥村 龍, 竹田 潔, 豊嶋 崇徳
    Source： 腸内細菌学雑誌 (1343-0882)34巻2号 Page114(2020.04)
  7. 造血幹細胞移植の現在と未来　造血幹細胞移植の現状と課題
    Author：豊嶋 崇徳
    Source： 血液事業 (0917-7833)43巻1号 Page147-149(2020.05)
  8. GVHDの病態生理に関する新たな知見
    Author：橋本 大吾
    Source： 臨床血液 (0485-1439)61巻8号 Page959-964(2020.08)
  9. PTCYを用いた同種造血幹細胞移植
    Author：杉田 純一
    Source： 臨床血液 (0485-1439)61巻9号 Page1402-1410(2020.09)
  10. 造血器腫瘍に対するキメラ抗原受容体(CAR)遺伝子改変T細胞療法
    Author：豊嶋 崇徳
    Source： 内科 (0022-1961)126巻3号 Page337-340(2020.09)
  11. 新型コロナウイルスの唾液検査
    Author：豊嶋 崇徳
    Source：熊医会報 1643: 28-29, 2020

和文症例報告

  1. 新生児におけるcisAB型の血液型検査反応性と発育に伴う抗原量の変化に関する検討
    Author：櫻澤 貴代, 高橋 秀一郎, 渡邊 千秋, 伊藤 誠, 魚住 諒, 増田 裕弥, 早坂 光司, 西田 睦, 杉田 純一, 豊嶋 崇徳
    Source： 日本輸血細胞治療学会誌 (1881-3011)66巻1号 Page31-35(2020.02)

和文原著

  1. 北海道大学保健センターで実施してきたダニ媒介性脳炎ワクチン摂取の安全性についての検討
    Author：川原由佳子、折戸智恵子、好井健太朗、橋野　聡
    Source：CAMPUS HEALTH 2020;57:95-100.

和文著書

  1. 豊嶋崇徳: 造血幹細胞移植（適応と方法）. 福井次矢, 高木　誠, 小室一成 編:今日の治療方針2020年版（Volume62）. 医学書院. pp.665-667. 東京, 2020.(分担執筆)
  2. 豊嶋崇徳：Ⅱ 口腔以外. 日本がんサポーティブケア学会、日本がん口腔支持療法学会編集. JASCCがん支持医療ガイドシリーズ　がん治療に伴う粘膜障害マネジメントの手引き 2020年版　金原出版株式会社　pp．106-162, 東京,　2020.（分担執筆）
  3. 豊嶋崇徳：リレーエッセイ「移植屋からコロナ屋へと」. Hematopaseo 7: 67, 2020
  4. 豊嶋崇徳：コロナウイルス唾液関連データ. 北海道医報 1223: 19, 2020
  5. 豊嶋崇徳【造血器腫瘍学(第2版)-基礎と臨床の最新研究動向-】造血器腫瘍の診断と治療　治療法　造血幹細胞移植(解説/特集), 日本臨床 (0047-1852)78巻増刊3 造血器腫瘍学 Page250-254(2020.08)
  6. 豊嶋崇徳：造血器腫瘍に対するCAR-T細胞(遺伝子改変T細胞)療法(解説/特集), Medical Practice (0910-1551)37巻9号 Page1417-1419(2020.09)
  7. 豊嶋崇徳, 木口 亨：同種造血幹細胞移植のドナー選択は?　第一選択はHLA適合同胞ドナー、第二選択は骨髄・臍帯血バンク、HLA半合致血縁ドナー(Q&A), 日本医事新報 (0385-9215)5035号 Page41(2020.10)
  8. 加畑　馨：再生医療等製品/遺伝子治療用製品の承認取得/審査の視点と実務戦略, サイエンス＆テクノロジー社
  9. 小野澤真弘：白血病治療マニュアル改訂第4版　第IV章支持療法の実際　5.肝炎ウイルス対策
  10. 後藤秀樹：白血病治療マニュアル - 改訂第4版- （南江堂）第４章：支持療法の実際「G-CSFの使用の実際」